1Fishel R, Lescoe MK, Rao MR, et al. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell,1993,75:1027-1038.
2Aaltonen LA, Peltomki P, Leach ES, et al. Clues to the pathogenesis of familial colorectal cancer. Science ,1993,260:812-815.
2Bernard-Marty C,Mano M,Paesmans M,et al.Second malignan cies following adjuvant chemotherapy:6-year results from a Belgian randomized study comparing cyclophosphamide,methotrexate and 5-fluorouracil (CMF) with an anthracy cycline-based regimen in adjuvant treatment of node-positive breast cancer patients[J].Ann Oncol,2003,14(5):693-698.
3Chung D C,Rustgi A K.The hereditary nonpolyposis colorectal cancer syndrome:genetics and clinical implications[J].Ann Intern Med,2003,138(7):560-570.
4Zhu Y M,Das-Gupta E P,Russell N H.Microsatellite instability and p53 mutations are associated with abnormal expression of the MSH2 gene in adult acute Leukemia[J].Blood,1999,94(2):733-740.
5Watanabe Y.Koi M,Hemmi H,et al.A change in microsatellite instability caused by cisplatin-based chemotherapy of ovarian cancer[J].Br J Cancer,2001,85(7):1064-1069.
6Paunesku T,Mittal S,Protic M,et al.Proliferating cell nuclear antigen (PCNA):ringmaster of the genome[J].Int J Radiat Biol,2001,77(10):1007-1021.
7Del Giglio A,Drach J,Kornblan S M,et al.Quantitative expres sion of proliferating cell nuclear antigen by western blot (PCNAWB) in peripheral blasts correlates with remission induction in patient with acute myelogenous[J].Leuk Lymphoma,1995,19(3-4):235-241.
